Documented in an LDA filing dated Oct 12, 2024
Sourced institutional rolesLDA lobbying records
MAURA KEEFE
MAURA KEEFE appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Nov 1, 2026
Source-backed chronology
Career Timeline
Prior government service disclosed in an LDA filing; exact dates not reported
Chief of Staff, Senator Shaheen -- 2009-2019, Chief of Staff, Rosa DeLauro 1997-2000; press secretary, Rosa DeLauro 1993-1996
Federal government
Inspect source ↗Federal LDA filings
Lobbying Activity
CVS HEALTH2nd Quarter (Apr 1 - June 30) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care. Issues related to continuation of prescription drug access and testing during COVID crisis.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. Issues related to the continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues related to dispensing of mifepristone. Issues related to Medicare Advantage plans.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care. Issues related to continuation of prescription drug access and testing during COVID crisis.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health. Issues related to affordable health insurance coverage during COVID crisis.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, and health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care. Issues related to the proposed CVS-Aetna merger.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. Issues related to the continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, and health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. Issues related to the continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care. Issues related to the proposed CVS-Aetna merger.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, and health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2023
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health. Issues related to affordable health insurance coverage during COVID crisis.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2022
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2025
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Pharmacy
Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2019
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of health care and prescription drug prices; quality health care, patient outcomes, health care delivery, smoking cessation and women's heart health.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2021
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2020
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2024
Registrant: KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS · Health Issues
Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.
LDA filing ↗